NYSE$OHI
Omega Healthcare Investors Inc · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
Omega Healthcare's Q3 2023 performance was marked by exceeding financial expectations, strategic investments, and balance sheet enhancements.
Omega Healthcare Investors reported a net income of $94 million, or $0.37 per common share, for the quarter ended September 30, 2023. The company completed $106 million in new investments, including real estate acquisitions and loans, and strengthened its balance sheet with a $429 million term loan. Revenues for the quarter totaled $242.0 million, an increase of $2.6 million over the same period in 2022.
- Net income for the quarter was $94 million, or $0.37 per common share.
- New investments of $106 million were completed, including real estate acquisitions and loans.
- A $429 million unsecured term loan was entered into to strengthen the balance sheet.
- 29 facilities that were leased to LaVie were sold for $305.2 million in consideration in Q4.
Headline financials
Revenue & EPS history
Omega Healthcare · Revenue · Quarterly
$242M
Revenue by segment
Omega Healthcare · $31.8M total across 3 segments · Q3 2023
- Real estate loans interest income$24.9M—78.2%
- Non-real estate loans interest income$5.73M—18.0%
- Miscellaneous income$1.21M+398.8%3.8%
Forward guidance
Omega Healthcare anticipates potential impacts on FAD in Q4 2023 and early 2024 due to ongoing restructurings and tenants on cash-basis.
Tailwinds
- The company remains constructive on the longer-term opportunities within the industry.
- The operating backdrop continues to improve.
- Occupancy is increasing.
- The tight labor market is slowly moderating.
- The skilled nursing industry is well-positioned to benefit from multi-decade demographic tailwinds.
Headwinds
- Some smaller restructurings are ongoing.
- Many tenants are still on a cash-basis.
- Some security deposits are being depleted.
- FAD could be impacted by these factors in the fourth quarter and potentially into early 2024.
- CMS issued its proposed rule on minimum staffing for the industry, which could have fundamental flaws.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
-0.1%
Avg return
Earnings day
+0.2%
Avg return
5 days after
+2.4%
Avg return
30 days after
49%
33 / 68 earnings
Positive
+13.1%
Q1 2022
Best reaction
-9.1%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.0% | -2.6% | -1.3% | |
| Q4 2025 | +6.1% | +5.8% | +11.0% | |
| Q3 2025 | +5.3% | +7.9% | +15.2% | |
| Q1 2025 | -4.1% | -7.5% | -4.0% | |
| Q4 2024 | -0.7% | -6.0% | -3.7% | |
| Q3 2024 | +1.4% | -4.5% | -3.0% | |
| Q2 2024 | +5.1% | +1.8% | +8.6% | |
| Q1 2024 | +2.1% | +0.8% | +5.3% | |
| Q4 2023 | +6.9% | +10.2% | +9.9% | |
| Q3 2023 | -5.2% | -5.8% | -3.4% | |
| Q2 2023 | -1.1% | +1.0% | +3.2% | |
| Q1 2023 | +8.5% | +7.9% | +10.4% | |
| Q4 2022 | -2.2% | -5.1% | -7.9% | |
| Q3 2022 | -1.3% | +2.5% | -5.1% | |
| Q2 2022 | +1.8% | +3.2% | +5.4% | |
| Q1 2022 | +13.1% | +11.3% | +15.9% | |
| Q4 2021 | -8.4% | -11.2% | -8.7% | |
| Q3 2021 | +0.2% | -4.7% | -7.6% | |
| Q2 2021 | -4.6% | -3.2% | -6.9% | |
| Q1 2021 | -2.0% | -3.9% | -0.1% | |
| Q4 2020 | -0.6% | -1.2% | +1.2% | |
| Q3 2020 | -1.1% | +3.8% | +23.1% | |
| Q2 2020 | +3.0% | +4.8% | -0.2% | |
| Q1 2020 | +0.0% | +1.8% | +21.9% | |
| Q4 2019 | -0.0% | +1.4% | -7.7% | |
| Q3 2019 | -2.2% | -5.4% | -2.6% | |
| Q2 2019 | +1.5% | +7.8% | +15.4% | |
| Q1 2019 | +1.5% | +4.3% | +2.3% | |
| Q4 2018 | -5.9% | -6.9% | -6.5% | |
| Q3 2018 | +5.2% | +7.5% | +15.6% | |
| Q2 2018 | +3.7% | +5.5% | +10.9% | |
| Q1 2018 | +3.4% | +7.0% | +13.1% | |
| Q4 2017 | -2.9% | +1.4% | +3.7% | |
| Q3 2017 | -9.1% | -10.6% | -15.6% | |
| Q2 2017 | -3.4% | -4.9% | -5.8% | |
| Q1 2017 | -2.6% | -0.8% | -3.3% | |
| Q4 2016 | -5.0% | -1.8% | -3.7% | |
| Q3 2016 | -1.7% | -6.5% | -5.8% | |
| Q2 2016 | +1.5% | +1.9% | +3.5% | |
| Q1 2016 | -1.2% | — | — | |
| Q4 2015 | +4.4% | — | — | |
| Q3 2015 | -0.5% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | -0.7% | — | — | |
| Q3 2014 | +1.8% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | -0.6% | — | — | |
| Q4 2013 | -1.4% | — | — | |
| Q3 2013 | -2.0% | — | — | |
| Q2 2013 | -7.3% | — | — | |
| Q1 2013 | +0.5% | — | — | |
| Q4 2012 | +4.2% | — | — | |
| Q3 2012 | -3.0% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2012 | +0.4% | — | — | |
| Q4 2011 | -1.8% | — | — | |
| Q3 2011 | +2.2% | — | — | |
| Q2 2011 | +3.2% | — | — | |
| Q1 2010 | +0.1% | — | — | |
| Q1 2011 | +1.3% | — | — | |
| Q4 2008 | -2.2% | — | — | |
| Q4 2010 | -2.2% | — | — | |
| Q3 2010 | -4.4% | — | — | |
| Q3 2009 | -4.4% | — | — | |
| Q2 2009 | +1.3% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro